Granules India receives ANDA approval

Uniindia: Mumbai, Aug 30 (UNI) Pharma major Granules India on Tuesday said the US Food and Drug Administration (USFDA) has approved its Abbreviated New Drug Application (ANDA) for Loperamide Hydrochloride and Simethicone Tablets, 2 mg/125 mg (OTC).

Related Keywords

Mumbai ,Maharashtra ,India , ,Johnson Consumer Inc ,Drug Administration ,Mcneil Consumer Healthcare Division ,Granules India ,Abbreviated New Drug Application ,Loperamide Hydrochloride ,Simethicone Tablets ,Imodium Multi Symptom Relief Tablets ,Mcneil Consumer Healthcare ,Business ,Economy ,